Should I buy Agilent Technologies (A) stock or is it too late?
⭐ The most reliable of them, either direction: Bernstein — 69% of its targets hit on this sector (70 calls tested). It aims for $180 (+4.9 %), call made on August 28, 2026, maturing on August 28, 2027 (47 d ago).
Firm-by-firm track record on Agilent Technologies
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wells Fargo | 78 % | +21.5 % | 18 | $180 +5% |
| Goldman Sachs | 78 % | +18.1 % | 9 | $175 +2% |
| Baird | 61 % | +12.8 % | 23 | $156 -9% |
| Evercore ISI Group | 60 % | +11.6 % | 5 | $172 +0% |
| JP Morgan | 69 % | +11.2 % | 13 | $190 +11% |
| Barclays | 67 % | +10.6 % | 18 | $195 +14% |
| Morgan Stanley | 86 % | +10.4 % | 14 | $190 +11% |
| Citigroup | 64 % | +9.7 % | 11 | $190 +11% |
✅ Reasons to believe
- 88% of analysts rate it a buy (Buy consensus, 16 ratings) — a sign of market conviction.
- The most reliable firm on A, Morgan Stanley (86% hit rate, 14 scored calls), targets $190 (call made on October 13, 2026, maturing on October 13, 2027) (+11%) in its most recent call, and $180 (call made on December 2, 2025, maturing on December 2, 2026) (+5%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 16 ratings, 2 are neutral.
- Limited upside: the median target is only +5% from the current price.
- High valuation (P/E ~34): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on A
Median target $180 (+5%) · 16 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Agilent Technologies now?
We won't decide for you. The facts: 88% of analysts rate it a buy, median target $180 (+5%), and Morgan Stanley (most reliable on A, 86%) targets $190. Weigh that against valuation (P/E ~34). This is not personalized advice.
Is it too late to invest in Agilent Technologies?
Not according to analysts: the median target ($180) is still +5% above the current price ($172) (most reliable on A: Morgan Stanley, 86%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Agilent Technologies still worth investing in?
It depends on the gap between the price ($172) and its estimated value: analysts target $180 on median (+5%), with 88% buys (most reliable on A: Morgan Stanley, 86%). Cross-check with their real reliability on A and the cautions above. Information, not advice.
What's the main risk in buying A?
The consensus is not unanimous: of 16 ratings, 2 are neutral.
→ Go deeper: the full Agilent Technologies profile (consensus, analyst reliability, price target, performance).